Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    Acquired/Mature, Tagged as ('cancer'), Small Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (2)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees (1)

    Location 

    Status 

    13 Startups 0 In the News 1 Recently Updated
    • Total Funding
      $77.15M
      Raised
      17
      Events
    • Private Funding
      $55.85M
      Raised
      9
      Rounds
    • Public Offerings
      $21.3M
      Raised
      5
      Offerings
    • M&A
      $0
      Raised
      3
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    Cellect Biotechnology logo

    Cellect Biotechnology

    Acquired
    Immune System Regeneration
    2011 B2B 11-50 Mature $24.26M
    therapeutics
    immunology
    regenerative-medicine
    cell-therapy
    bioprocess
    biotechnology
    medical-technologies
    stem-cells
    chronic-patients
    cancer
    medical-devices
    academia
    cancer-therapy
    diabetes
    pharma-companies
    laboratories
    healthcare-providers
    CANNDOC Pharma logo

    CANNDOC Pharma

    Acquired
    Pharma-grade Cannabis Products
    2008 B2B, B2B2C, B2C, B2G 11-50 Acquired Undisclosed
    cancer
    therapeutics
    parkinson
    epilepsy
    genetics
    pain-relief
    oncology
    inflammatory-diseases
    cannabis
    medical-cannabis
    oral-drugs
    pharmaceuticals
    Ayana Pharma logo

    Ayana Pharma

    Liposomal Drugs for Cancer Treatment
    2012 B2B 11-50 Mature Undisclosed
    cancer
    generic-drugs
    medical-technologies
    drug-delivery
    space-tech
    pharmaceuticals
    hospitals
    Aposense logo

    Aposense

    Drug Delivery via Electrical Nano Motors
    1996 B2B 11-50 Mature $47.3M
    gastroenterology
    cns-disorders
    pulmonary
    cancer
    oncology
    parkinson
    pharmaceuticals
    drug-delivery
    genetics
    nanotechnology
    pharma-companies
    Eventus Diagnostics logo

    Eventus Diagnostics

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Blood Test for Breast Cancer Diagnosis
    2010 B2B 11-50 Mature $2.72M
    antibodies
    iso
    diagnostics
    cancer
    medical-technologies
    blood-test
    doctors
    oncology
    nanotechnology
    artificial-intelligence
    algorithms
    machine-learning
    Convergent R.N.R. logo

    Convergent R.N.R.

    X-ray Focusing for Cancer Treatment
    2010 B2B 11-50 Mature $3.7M
    medical-technologies
    cancer
    oncology
    x-ray
    lenses
    radiology
    babies
    medical-devices
    healthcare-providers
    non-invasive
    hospitals
    children
    patients
    imaging
    optronics
    treatments
    bioconvergence
    Medial EarlySign logo

    Medial EarlySign

    Early Detection of Life-threatening Conditions
    2009 B2B 11-50 Mature $50M
    data-analytics
    risk-management
    early-detection
    patent-pending
    doctors
    cancer
    digital-healthcare
    diagnostics
    decision-making
    clinical-data
    hospitals
    healthcare-providers
    deep-learning
    personalization
    precision-medicine
    clinics
    big-data
    machine-learning
    artificial-intelligence
    decision-support
    emr
    diabetes

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    13 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $77.15M
      Raised
      17
      Events
    • Private Funding
      $55.85M
      Raised
      9
      Rounds
    • Public Offerings
      $21.3M
      Raised
      5
      Offerings
    • M&A
      $0
      Raised
      3
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    Cellect Biotechnology logo
    Raised
    $24.26M
    Cellect Biotechnology
    Acquired
    Immune System Regeneration
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    CANNDOC Pharma logo
    Raised
    Undisclosed
    CANNDOC Pharma
    Acquired
    Pharma-grade Cannabis Products
    Founded:2008
    Business Model:B2B, B2B2C, B2C, B2G
    Employees:11-50
    Funding Stage:Acquired
    Ayana Pharma logo
    Raised
    Undisclosed
    Ayana Pharma
    Liposomal Drugs for Cancer Treatment
    Founded:2012
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Aposense logo
    Raised
    $47.3M
    Aposense
    Drug Delivery via Electrical Nano Motors
    Founded:1996
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Eventus Diagnostics logo
    Raised
    $2.72M
    Eventus Diagnostics
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Blood Test for Breast Cancer Diagnosis
    Founded:2010
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Convergent R.N.R. logo
    Raised
    $3.7M
    Convergent R.N.R.
    X-ray Focusing for Cancer Treatment
    Founded:2010
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Medial EarlySign logo
    Raised
    $50M
    Medial EarlySign
    Early Detection of Life-threatening Conditions
    Founded:2009
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,